Effettuare il login Iscriviti gratis

Albireo Pharma Inc Entrate Q/Q

Cos'è Entrate Q/Q di Albireo Pharma Inc?

Entrate Q/Q di Albireo Pharma Inc è 168.34%

Qual è la definizione di Entrate Q/Q?

La crescita trimestrale dei ricavi, anno su anno , è l'aumento delle entrate di un'azienda rispetto alla performance nel corrispondente trimestre dell'anno precedente espresso in percentuale.

Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.

Entrate Q/Q di aziende nel Health Care settore su NASDAQ rispetto a Albireo Pharma Inc

Cosa fa Albireo Pharma Inc?

Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.

Aziende con entrate q/q simili a Albireo Pharma Inc